Korean J Gastroenterol.  2018 Sep;72(3):141-145. 10.4166/kjg.2018.72.3.141.

Pulmonary Extraintestinal Manifestation of Crohn's Disease Treated Successfully with Adalimumab

Affiliations
  • 1Division of Gastroenterology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea. cho6706@hanmail.net
  • 2Department of Pathology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
  • 3Department of Radiology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.

Abstract

Pulmonary extraintestinal manifestation is rare in Crohn's disease and has been reported in only a few cases. Despite the presence of pulmonary abnormalities in a significant proportion of patients with inflammatory bowel disease, there are only few case reports, due to complicated diagnosis and low recognition by clinicians. Currently, treatment guidelines for pulmonary Crohn's disease have not been established. There are some case reports of pulmonary Crohn's disease that achieved remission after infliximab treatment. Clinical and radiological remission of pulmonary extraintestinal involvement in Crohn's disease after adalimumab therapy has not been reported yet. Here, we report one case of lung involvement of Crohn's disease, which shows radiological and clinical remission after adalimumab treatment.

Keyword

Crohn disease; Inflammatory bowel diseases; Multiple pulmonary nodules; Extraintestinal manifestation

MeSH Terms

Adalimumab*
Crohn Disease*
Diagnosis
Humans
Inflammatory Bowel Diseases
Infliximab
Lung
Multiple Pulmonary Nodules
Adalimumab
Infliximab
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error